Burden of migraine among Egyptian people: prevalence and comorbidities

Table 5 Migraine among study participants and their associations with participants’ insomnia, depression, anxiety, and stress levels (n = 2533)

Variables	Migraine Screening				OR (95% CI, P-value) (univariate)	aOR (95% CI, multivariate)
	Negative		Positive
	n	%	n	%
Insomnia Severity
No clinically significant insomnia	1190	89.1	145	10.9	1	1
Subthreshold insomnia	660	72.4	252	27.6	3.13 (2.51–3.93)**	2.4 (1.89–3.05)**
Moderate severity	141	54.9	116	45.1	6.75 (5.00-9.12)**	3.89 (2.79–5.43)**
Severe	13	44.8	16	55.2	10.10 (4.77–1.78)**	4.36 (1.97–9.64)**
Depression Score
Normal	1444	84.7	261	15.3	1	1
Moderate	429	70.1	183	29.9	2.36 (1.90–2.93)**	1.05 (0.8–1.37)
Severe	131	60.6	85	39.4	3.59 (2.65–4.85)**	0.86 (0.56–1.33)
Anxiety Score
Normal	1123	87.5	160	12.5	1	1
Moderate	668	75.6	216	24.4	2.27 (1.81–2.85)**	1.3 (0.99–1.7)
Severe	213	58.2	153	41.8	5.04 (3.87–6.58)**	1.8 (1.24–2.6)**
Stress Score
Normal	1350	86.8	205	13.2	1	1
Moderate	514	70.5	215	29.5	2.75 (2.22–3.42)**	1.62 (1.24–2.12)**
Severe	140	56.2	109	43.8	5.13 (3.83–6.85)**	2.35 (1.56–3.53)**

* P value significance ≤ 0.05. **P value < 0.01
*Abbreviations: OR (Odds ratio), aOR (adjusted odds ratio), CI (Confidence interval)

ISSN: 1129-2377